Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Oral supplementation of vitamin D
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mental Health Wellness 1
1 trial -
Oxytocin
United Therapeutics Europe Ltd
Posttraumatic Stress Disorder
1 trial -
Oxytocin
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Social Behavior
1 trial -
Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postpartum Hemorrhage
1 trial -
PCSK9 inhibitor (PCSK9i)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
PET imaging
Cardiff Oncology
Pituitary Adenoma
1 trial -
PGS 2.0
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Recurrent Pregnancy Loss
1 trial -
PSMA PET/CT
The First People's Hospital of Lianyungang
Prostate Adenocarcinoma
1 trial -
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The First People's Hospital of Lianyungang
Prostate Cancer Screening
1 trial -
Paclitaxel Oral Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-Small-Cell Lung Cancer
1 trial -
Papillary epinephrine spraying
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatitis
1 trial -
Paroxetine
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Disorder
1 trial -
Partially Hydrolyzed Whey Protein Formula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mild Allergic Symptoms in Infants
1 trial -
Phase 1 Wonderlab Product
Chongqing Precision Biotech Co., Ltd
Diabetes
1 trial -
Photo-responsive nanozyme
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Dermatitis
1 trial -
Phytosterols & placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-alcoholic Fatty Liver Disease
1 trial -
Ping On Ointment
The University of Hong Kong
Temporomandibular Disorders
1 trial -
Pitavastatin and placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dyslipidemia
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
2 trials -
Placebo
Regeneron Ireland Designated Activity Company (DAC)
Knee Osteoarthritis
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorder
1 trial -
Placebo 1 to Probiotic A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Dysfunction
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources